Skip to main content
. 2020 Mar 10;11:252. doi: 10.3389/fphar.2020.00252

FIGURE 4.

FIGURE 4

Pre-treatment of HLJDD reduced intestinal cell apoptosis and improved renewal in chemotherapy-treated mice. (A) Showed that pre-treatment of HLJDD could significantly reduce the positive TUNEL signal in the intestinal section of chemotherapy-treated mice; (B) showed that pre-treatment of HLJDD could significantly reduce the expression of cleaved caspases-3 in the intestinal section of chemotherapy-treated mice; (C) showed that pre-treatment of HLJDD could significantly improve the renewal-associated Ki67 expression in the intestinal section of chemotherapy-treated mice. *p < 0.05, **p < 0.01, ***p < 0.001 when compared with the model group.